The global home infusion therapy market was valued at USD 25.16 billion in 2020 and is projected to grow at a CAGR of 7.6% during the forecast period. Factors driving the growth of the home infusion therapy market include inclination towards home health care, growing hospital-acquired infections and rising number of enduring diseases.
The global home infusion therapy market is segmented based on product and application. On the basis of product, the market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pumps was the largest market in 2019. By application, the market is segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals and others. The anti-infective segment accounted for the largest share of the global home infusion therapy market.
Regionally, North America accounted for the largest market share of the global home infusion therapy market attributable to increasing acceptance of innovative technology in infusion pumps. Leading players of the global home infusion therapy market include B. Braun Melsungen, Fresenius Kabi, Baxter, Becton, Dickinson & Company, Smiths Medical, Eli Lilly & Company, Terumo Corporation, Caesarea Medical Electronics, ICU Medical, CareFusion Corporation among others.
Key segments of the global home infusion therapy market
Product Overview, 2018-2028 (USD Billion)
- Infusion Pumps
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Application Overview, 2018-2028 (USD Billion)
- Hydration Therapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
Regional Overview, 2018-2028 (USD Billion)
- North America
- United Kingdom
- Asia Pacific
- South America
- Middle East & Africa
- South Africa
Reasons for the study
- Rising prevalence of chronic disease
- Growing hospital-acquired infection
- Presence of home healthcare facilities
What does the report include?
- The study on the global home infusion therapy market includes qualitative factors such as drivers, restraints and opportunities
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product and application. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global home infusion therapy market is suitable for all the players across the value chain including product manufacturing companies, suppliers/distributors, R&D labs, CROs, healthcare organizations, medical reimbursement and insurance providers
- Venture capitalists and investors looking for more information on the future outlook of the global home infusion therapy market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global home infusion therapy market
Infusion therapy has drifted and progressed past the very first infusion therapies managed in at home: total parenteral nutrition (TPN) and antibiotics. As extensive tenure vascular admittance devices and smaller, new ambulatory pumps, infusers, and implantable pumps came into the market, patients have practiced better freedom. Nowadays, equipment’s for infusion therapy are proficient in conferring the needs of medically urbane patients in the nonclinical location. Different home infusion pharmacies have recognized processes for managing services based on the kind of nursing care provided; nevertheless, no uniform process subsists for all providers, including acute care hospitals, to follow as patients are transferred from the hospital back to the homegrown with infusion therapy. Home infusion medicines are made and distributed by a registered pharmacy; though, home infusion nursing care can be delivered by nurses working with the pharmacy, a registered home health agency, or nurses functioning in a doctor’s office or outpatient clinic site.
The anti-infective segment dominated the global home infusion therapy market in 2019. Information on home use of a mass of drug infusion treatments can be established in the literature. Undoubtedly, the utmost common group of drugs is antibiotics and other anti-infectives. Home antibiotic therapy is testified to be operational in above 90% of cases.
The safety and efficacy of anti-infective drugs in persons who are healthy in all respects excluding the infection being treated are well recognized, but their consumption in the home needs special care because of the incapacities of the patients treated, the host of therapies these patients might require, and the probable toxicity of many of the medications they take.
Healthcare distribution in the United States is swiftly changing with several forces pouring the change. The elderly population, almost half of which have a chronic health condition, has added to increasing healthcare costs. Healthcare workers are altering, including staff scarcities and the type of workforce desired. Yearly growth of healthcare outlay has exceeded the rate of inflation for several years, with the burden gradually take up by customers.
In the U.S. home infusion organizations are evaluating different forms of technology for instance interoperable equipment, mobile apps, smart pumps, telehealth and electronic health records. These technologies can augment continuity of care, permitting faster retorts to potential emergencies in the patient’s household and better clinical choices through involvement of health data points.